Table 2.
Scores (Mean and SD) at baseline and 1-month follow-up, group by time interaction and between-group effect size.
| Measures | Propranolol group (reference group) | Placebo group | Group by time interaction |
Effect sizes of propranolol vs. placebo group |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At 1-month follow-up | ||||||||||||||
| Baseline score | SD | Follow-up score | SD | Baseline score | SD | Follow-up score | SD | Coefficient | 95%-CI | p | ||||
| Lower bound | Upper bound | |||||||||||||
| S-DAI | n | 19 | 19 | 17 | 17 | |||||||||
| 32.11 | 7.26 | 29.05 | 8.82 | 31.59 | 7.53 | 27.12 | 6.55 | −1.42 | −5.54 | 2.70 | 0.50 | 0.23 | ||
| Intra-operative state anxiety score | n | 19 | 19 | 17 | 17 | |||||||||
| 56.32 | 21.55 | 70.68 | 27.18 | 66.18 | 27.91 | 61.76 | 26.99 | −18.78 | −40.20 | 2.64 | 0.09 | 0.59 | ||
| Specific phobia diagnoses | n | 19 | 19 | 17 | 17 | |||||||||
| 26.30% | 21.05% | 29.41% | 5.88% | −2.50 | −6,71 | 1.72 | 0.25 | 0.082 | ||||||